• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

    10/4/23 4:05:00 PM ET
    $KRMD
    $MCK
    Medical/Dental Instruments
    Health Care
    Other Pharmaceuticals
    Health Care
    Get the next $KRMD alert in real time by email

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced that Edward Wholihan was appointed to the Company's Board of Directors on September 28, 2023 to fill the vacancy that followed the Company's 2023 Annual Meeting of Shareholders.

    "I am extremely proud to welcome a highly accomplished executive such as Ed to our Board of Directors. He will be a valuable addition and we will benefit from his breadth of experience and success creating shareholder value in high-growth life science and healthcare businesses," said Linda Tharby, KORU Medical's President and CEO. "As we continue to build our leadership position in the subcutaneous infusion market with our FREEDOM Infusion System, Ed's insights will meaningfully contribute to our future growth and success."

    Edward Wholihan joins KORU Medical's Board of Directors with over 25 years of experience as Chief Financial Officer driving growth and shareholder value for public, private equity-sponsored, and venture capital-funded life sciences and healthcare businesses. Most recently, he has leveraged his strategic management, financial, and operational expertise consulting for various companies. Prior, he served as the Chief Financial Officer for Rarebreed Veterinary Partners, Inc, a community of veterinary hospitals; CFO of Allena Pharmaceuticals, Inc., a development stage biopharmaceutical company; and CFO of Medical Specialties Distributors, a leading solution provider to the specialty pharmacy, home infusion, and oncology practice markets that was acquired by McKesson Corp (NYSE:MCK) in 2018. Ed also held two other CFO roles within the life science sector earlier in his career and, prior to that, spent seven years as a management strategy consultant for McKinsey & Company. He earned his MBA from Stanford University's Graduate School of Business and a BA in economics from Yale University.

    "I am impressed with KORU Medical's tremendous progress, innovation, and commitment toward growth, and I am excited to take part in helping the Company achieve its goal of improving the quality of life for patients around the world," said Mr. Wholihan. "I look forward to supporting Linda and the KORU Medical team as they continue to drive the Company's growth strategy and the provision of subcutaneous infusion therapies and their benefits to patients."

    About KORU Medical Systems

    KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM™ Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231004632683/en/

    Get the next $KRMD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $KRMD
    $MCK

    CompanyDatePrice TargetRatingAnalyst
    KORU Medical Systems Inc.
    $KRMD
    2/14/2025$4.50Overweight → Neutral
    Piper Sandler
    McKesson Corporation
    $MCK
    12/4/2024$630.00Neutral
    Mizuho
    McKesson Corporation
    $MCK
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/5/2024$670.00 → $665.00Outperform
    Leerink Partners
    McKesson Corporation
    $MCK
    8/8/2024$540.00 → $570.00Neutral
    Mizuho
    KORU Medical Systems Inc.
    $KRMD
    7/25/2024$4.00Buy
    B. Riley Securities
    McKesson Corporation
    $MCK
    2/26/2024$600.00Outperform
    Leerink Partners
    More analyst ratings

    $KRMD
    $MCK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Manko Joseph M. Jr. bought $349,999 worth of shares (145,833 units at $2.40) and sold $349,999 worth of shares (145,833 units at $2.40) (SEC Form 4)

      4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

      12/15/23 4:05:24 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care

    $KRMD
    $MCK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

      KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2025 financial results on Wednesday, August 6, 2025. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for internationa

      7/16/25 4:05:00 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

      KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Adam Kalbermatten as Chief Commercial Officer, effective July 28, 2025. Adam brings over two decades of commercial leadership experience in the medical device and pharmaceutical industries, with a proven track record of scaling businesses, building high-performing teams, and delivering customer-focused innovation. As Chief Commercial Officer, he will oversee all aspe

      7/7/25 4:05:00 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

      McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

      6/26/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $KRMD
    $MCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Tyler Brian S. sold $13,716,411 worth of shares (19,371 units at $708.09), decreasing direct ownership by 41% to 27,872 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      7/14/25 4:51:43 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Director Cascella Robert was granted 4,189 shares, increasing direct ownership by 5% to 84,615 units (SEC Form 4)

      4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

      7/2/25 5:17:08 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • Director Wholihan Edward was granted 4,189 shares, increasing direct ownership by 12% to 37,772 units (SEC Form 4)

      4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

      7/2/25 4:56:36 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care

    $KRMD
    $MCK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KORU Medical Systems downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded KORU Medical Systems from Overweight to Neutral and set a new price target of $4.50

      2/14/25 8:08:51 AM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • Mizuho resumed coverage on McKesson with a new price target

      Mizuho resumed coverage of McKesson with a rating of Neutral and set a new price target of $630.00

      12/4/24 7:43:38 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded McKesson from Neutral to Outperform and set a new price target of $688.00 from $531.00 previously

      11/7/24 6:29:13 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $KRMD
    $MCK
    Leadership Updates

    Live Leadership Updates

    See more
    • KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

      KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Adam Kalbermatten as Chief Commercial Officer, effective July 28, 2025. Adam brings over two decades of commercial leadership experience in the medical device and pharmaceutical industries, with a proven track record of scaling businesses, building high-performing teams, and delivering customer-focused innovation. As Chief Commercial Officer, he will oversee all aspe

      7/7/25 4:05:00 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

      KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company is set to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the Russell indexes annual reconstitution, effective after the US market opens on June 30, 2025, according to a preliminary list of additions posted Friday, June 6, 2025. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by tot

      6/11/25 4:05:00 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core Ventures

      Acquisition enhances McKesson's integrated oncology platform; Florida Cancer Specialists & Research Institute to join The US Oncology Network McKesson Corporation (NYSE:MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists & Research Institute, LLC (FCS), a leading physician-owned community oncology practice. FCS physicians will continue to retain a minority interest in Core Ventures. McKesson will purchase its controlling interest for approximately $2.49 bil

      8/26/24 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $KRMD
    $MCK
    Financials

    Live finance-specific insights

    See more
    • KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

      KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2025 financial results on Wednesday, August 6, 2025. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for internationa

      7/16/25 4:05:00 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

      McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

      6/26/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Completes Acquisition of Core Ventures

      Strengthens Community-Based Oncology Care with Florida Cancer Specialists & Research Institute Core Ventures McKesson Corporation (NYSE:MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC (FCS). The acquisition advances community-based oncology care and enables McKesson to continue to accelerate clinical development, improve patient outcomes, and expand access to quality cancer care in local communities. McKesson acquired an approximate 70% controlling intere

      6/3/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $KRMD
    $MCK
    SEC Filings

    See more
    • SEC Form 144 filed by McKesson Corporation

      144 - MCKESSON CORP (0000927653) (Subject)

      7/11/25 10:43:52 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by McKesson Corporation

      DEFA14A - MCKESSON CORP (0000927653) (Filer)

      7/2/25 4:18:08 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by McKesson Corporation

      DEFA14A - MCKESSON CORP (0000927653) (Filer)

      6/20/25 4:26:12 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $KRMD
    $MCK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by KORU Medical Systems Inc.

      SC 13G/A - KORU Medical Systems, Inc. (0000704440) (Subject)

      11/14/24 7:00:30 AM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by KORU Medical Systems Inc.

      SC 13G/A - KORU Medical Systems, Inc. (0000704440) (Subject)

      11/13/24 4:23:54 PM ET
      $KRMD
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by KORU Medical Systems Inc.

      SC 13G - KORU Medical Systems, Inc. (0000704440) (Subject)

      5/23/24 7:00:28 AM ET
      $KRMD
      Medical/Dental Instruments
      Health Care